|
|
| MRD / Regn No. |
: SG002536 |
Date |
: 06/06/2026 |
| Patient Name |
: Hazi Md Abdus Sattar |
Age & Gender |
: 58 Yrs. / Male |
| Contact No. |
: 01732998406 |
UHID |
: |
| Ht / Wt / BMI |
: 171 / 85 / 29.07 |
BP S / BP D |
: 97 / 77 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (24/May/2019) | HYPERTENSION (24/May/2014) | DYSLIPIDEMIA (24/May/2024) | BENIGN PROSTATIC HYPERPLASIA (24/May/2024) | OSA (08/May/2025) | |
|
Plan |
: |
CONTINUE OTHER MEDICINES BY CARDIOLOGIST |
|
| Salient Investigations |
: |
CREATININE: 1.4 | EGFR EGLOMERULAR FILTRATION RATE: 55.45 mL/min/1.73m2 | HB HEMOGLOBIN: 16.4 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 13.8 % | LDL LOW DENSITY LIPOPROTEIN: 71 mg/dL | MICROALBUMIN CREATININE RATIO: 46.8 mcg/mg | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES |
SQ |
0-0-40 |
BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
GLIMEPIRIDE 4 MG + METFORMIN 1000 MG
GLYCOMET GP 4 FORTE |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
3 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
4 |
ANTIHYPERGLYCEMIC SEMAGLUTIDE 5.0 MG
OZEMPIC 0.5 MG |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
5 |
ASPIRIN 75 MG + ATORVASATAIN 40 MG
ECOSPRIN AV 40 MG |
PO |
0-0-1 |
AFTER DINNER
|
TILL NEXT VISIT |
|
|
6 |
TELMISARTAN 40 MG + METOPROLOL 50 MG
METOSARTAN |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 06/Dec/2026 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE |
| |
|
| |
|
